She received her MD in Genetics in 2005 at the University Paris Descartes, her PhD in Neuroscience in 2010 at UPMC and is board certified in inborn errors of metabolism. Dr Mochel runs a Neurometabolic clinic at La Pitié-Salpêtrière university hospital. She is co-chair of the French society for inborn of errors of metabolism in adults (SFEIMA) and has recently joined the council of the Society for the Study of Inborn Errors of Metabolism (SSIEM). Her research is focused on the characterization and treatment of brain energy deficiencies in neurogenetic and neurometabolic diseases, especially Huntington disease and GLUT1 deficiency syndrome. Her major areas of expertise are the identification of neurometabolic biomarkers in vitro (metabolomics) and in vivo (nuclear magnetic resonance spectroscopy) as well as therapeutic approaches targeting the Krebs cycle.